We have previously shown that tumor-suppressive cell competition is driven by the apical transmembrane protein Sas and its receptor Ptp10D, a type III receptor-type protein tyrosine phosphatase (RPTP), which inhibits Egfr signaling [20]. The gene discussed is EGFR; the disease is neoplasm.